EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Mitochondria‐Specific Nanomedicine for Synergistic Chemo‐Photothermal Therapy and Immunogenic Activation Against Breast Cancer

Min Li, Jiangqi Feng, Junyang Zhuang, Qingguo Zhong, Yanda Li, Yanzhuo Lv, Shaoteng Huang, Xiangyu Huang, Mingbo Zhang, Xiaofeng Cai, Yuxin Wang, Wenping Chen und 4 weitere

Advanced Science · 2026-05 · 13 (29)

DOI: 10.1002/advs.202522226 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 25.02.2026. Verfasst von Min Li und 15 weiteren Autor:innen. Beteiligte Einrichtung: Fujian Key Laboratory of Drug Target Discovery and Structural and Functional Research, School of Pharmacy, Fujian Medical University, Fuzhou, China. Hauptthemen laut MEDLINE: Mitochondria, Photothermal Therapy, Nanomedicine, Breast Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Fujian Province, Fujian Science and Technology Innovation Joint Fund Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The presence of “cold” tumors in the tumor site is characterized with poor immune cell infiltration and resistance to conventional cancer therapies. To address these challenges, we developed an amphiphilic peptide dendrimer‐based multifunctional drug delivery system for integrating photothermal therapy (PTT), chemotherapy, and immunogenic cell death (ICD) to overcome the limitations of single‐modality treatments. Efficient drug delivery via the nanoplatform is realized through improving circulation stability, facilitating accumulation and penetration in tumor tissues, promoting cellular uptake, and accelerating tumor microenvironment‐responsive drug release. The mitochondria‐targeting property is derived from a mitochondria‐specific photothermal agent and a lipophilic cationic structure in the amphiphilic dendrimer, and it allows selective mitochondrial accumulation and disruption of the mitochondrial function. In vivo and in vitro studies confirm that PTT synergizes with chemotherapy to significantly enhance therapeutic efficacy, effectively induce ICD to modulate the tumor microenvironment, and strengthen antitumor responses. This nanoplatform enhances drug delivery, induces mitochondrial dysfunction, and achieves potent therapeutic effects, therefore, it could be fine‐tuned to become versatile for combination cancer therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MitochondriaPhotothermal TherapyNanomedicineBreast NeoplasmsDrug Delivery SystemsFemaleHumansAnimalsMiceTumor MicroenvironmentCell Line, TumorCombined Modality TherapyAntineoplastic Agents

Stichwörter der Autor:innen

amphiphilic peptide dendrimerimmunogenic cell deathmitochondria‐specificsynergic therapiestranscytosis

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Fujian Key Laboratory of Drug Target Discovery and Structural and Functional Research, School of Pharmacy, Fujian Medical University, Fuzhou, China.
  • Department of Chemistry, University College London, London, UK.
  • School of Medicine, Fuzhou University, Fuzhou, China.
  • Department of Radiology, Huaxi MR Research Center (HMRRC), Institution of Radiology and Medical Imaging, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy, West China Hos…

ORCID-Profile: Kui Luo

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Fujian Province
  • Fujian Science and Technology Innovation Joint Fund Project
  • Guangxi Key Laboratory of Molecular Medicine in Liver Injury and Repair

Zitieren

APA

Li, M., Feng, J., Zhuang, J., Zhong, Q., Li, Y., Lv, Y., Huang, S., Huang, X., Zhang, M., Cai, X., Wang, Y., Chen, W., Duan, Z., Chen, Z., Luo, K., & Li, N. (2026). A Mitochondria‐Specific Nanomedicine for Synergistic Chemo‐Photothermal Therapy and Immunogenic Activation Against Breast Cancer. Advanced Science, 13(29). https://doi.org/10.1002/advs.202522226

Vancouver

Li M, Feng J, Zhuang J, Zhong Q, Li Y, Lv Y, et al. A Mitochondria‐Specific Nanomedicine for Synergistic Chemo‐Photothermal Therapy and Immunogenic Activation Against Breast Cancer. Advanced Science. 2026;13(29). doi:10.1002/advs.202522226

BibTeX
@article{Li2026,
  author = {Li, Min and Feng, Jiangqi and Zhuang, Junyang and Zhong, Qingguo and Li, Yanda and Lv, Yanzhuo and Huang, Shaoteng and Huang, Xiangyu and Zhang, Mingbo and Cai, Xiaofeng and Wang, Yuxin and Chen, Wenping and Duan, Zhenyu and Chen, Zhou and Luo, Kui and Li, Ning},
  title = {A Mitochondria‐Specific Nanomedicine for Synergistic Chemo‐Photothermal Therapy and Immunogenic Activation Against Breast Cancer},
  journal = {Advanced Science},
  year = {2026},
  volume = {13},
  number = {29},
  doi = {10.1002/advs.202522226}
}
Kostenlos starten →